{
    "xml": "<topic id=\"PHP356\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/atropine-sulfate\" basename=\"atropine-sulfate\" title=\"ATROPINE SULFATE\">\n<title>ATROPINE SULFATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_343\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/atropine\">Atropine</xref>\n</p>\n<data name=\"vtmid\">73949004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_567112641\" title=\"Antimuscarinics\">Antimuscarinics</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34553\" title=\"ANTIMUSCARINICS (EYE)\" namespace=\"/drug-classes/antimuscarinics-eye\">ANTIMUSCARINICS (EYE)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" namespace=\"/drug-classes/antimuscarinics-systemic\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">   </data>\r\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">   </data>\r\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP49130\" outputclass=\"indicationsAndDose\" rev=\"1.56\" parent=\"/drugs/atropine-sulfate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Cycloplegia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye using eye drop</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Anterior uveitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye using eye drop</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bradycardia due to acute massive overdosage of beta-blockers</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>40&#8239;micrograms/kg (max. per dose 3&#8239;mg).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>3&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of poisoning by organophosphorus insecticide or nerve agent (in combination with pralidoxime chloride)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>20&#8239;micrograms/kg every 5&#8211;10&#8239;minutes (max. per dose 2&#8239;mg) until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;mg every 5&#8211;10&#8239;minutes until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasm</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;1.2&#8239;mg daily, dose to be taken at night.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Premedication</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Intra-operative bradycardia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>0.6&#8211;1.2&#8239;mg.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;1.2&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Excessive bradycardia associated with beta-blocker use</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>0.6&#8211;2.4&#8239;mg every hour in divided doses (max. per dose 600&#8239;micrograms).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Bradycardia following myocardial infarction (particularly if complicated by hypotension)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;micrograms every 3&#8211;5&#8239;minutes; maximum 3&#8239;mg.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49030\" outputclass=\"unlicensedUse\" rev=\"1.23\" parent=\"/drugs/atropine-sulfate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph> in children</p>\n<p>Not licensed for use in children for uveitis.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use in children</p>\n<p>Not licensed for use by oral route.</p>\n<p>Not licensed for use in children under 12 years for intra-operative bradycardia or by intravenous route for premedication.</p>\n<p>Not licensed for the control of muscarinic side-effects of edrophonium in reversal of competitive neuromuscular block.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49206\" outputclass=\"importantSafetyInformation\" rev=\"1.19\" parent=\"/drugs/atropine-sulfate\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49054\" outputclass=\"sideEffects\" rev=\"1.34\" parent=\"/drugs/atropine-sulfate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph> in children</p>\n<p>Toxic systemic reactions can occur in neonates and children.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph>\n</p>\n<p>Systemic side-effects can occur, particularly in children and the elderly.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49116\" outputclass=\"pregnancy\" parent=\"/drugs/atropine-sulfate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Not known to be harmful; manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64567\" outputclass=\"breastFeeding\" parent=\"/drugs/atropine-sulfate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>May suppress lactation; small amount present in milk&#8212;manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49022\" outputclass=\"monitoringRequirements\" parent=\"/drugs/atropine-sulfate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p outputclass=\"title\">Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block</p>\n<p>Since atropine has a shorter duration of action than neostigmine, late unopposed bradycardia may result; close monitoring of the patient is necessary.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64595\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/atropine-sulfate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>For administration <i>by mouth</i>, injection solution may be given orally.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58350\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.19\" parent=\"/drugs/atropine-sulfate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph>\n</p>\n<p>Although multi-dose atropine sulphate eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49017\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.16\" parent=\"/drugs/atropine-sulfate\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Atropine tablets less suitable for prescribing. Any clinical benefit as a gastro-intestinal antispasmodic is outweighed by atropinic side-effects.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48979\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.19\" parent=\"/drugs/atropine-sulfate\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use</p>\n<p>Prescription only medicine restriction does not apply where administration is for saving life in emergency.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP356-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/atropine-sulfate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: eye drops, solution for injection, oral suspension, solution for infusion, oral solution, eye ointment</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74804\" title=\"Tablet\" namespace=\"/drugs/atropine-sulfate/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75069\" title=\"Solution for injection\" namespace=\"/drugs/atropine-sulfate/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75143\" title=\"Eye drops\" namespace=\"/drugs/atropine-sulfate/eye-drops\">Eye drops</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78105\" namespace=\"/treatment-summaries/cardiopulmonary-resuscitation\" title=\"Cardiopulmonary resuscitation\" count=\"1\" rel=\"backlink\">Cardiopulmonary resuscitation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78171\" namespace=\"/treatment-summaries/sympathomimetics\" title=\"Sympathomimetics\" count=\"1\" rel=\"backlink\">Sympathomimetics</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78203\" namespace=\"/treatment-summaries/cardiac-glycosides\" title=\"Cardiac glycosides\" count=\"1\" rel=\"backlink\">Cardiac glycosides</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78219\" namespace=\"/treatment-summaries/antispasmodics\" title=\"Antispasmodics\" count=\"4\" rel=\"backlink\">Antispasmodics</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78291\" namespace=\"/treatment-summaries/arrhythmias\" title=\"Arrhythmias\" count=\"2\" rel=\"backlink\">Arrhythmias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78426\" namespace=\"/treatment-summaries/neuromuscular-blockade\" title=\"Neuromuscular blockade\" count=\"1\" rel=\"backlink\">Neuromuscular blockade</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78500\" namespace=\"/treatment-summaries/pre-medication-and-peri-operative-drugs\" title=\"Pre-medication and peri-operative drugs\" count=\"4\" rel=\"backlink\">Pre-medication and peri-operative drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78505\" namespace=\"/treatment-summaries/neuromuscular-disorders\" title=\"Neuromuscular disorders\" count=\"2\" rel=\"backlink\">Neuromuscular disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78525\" namespace=\"/treatment-summaries/mydriatics-and-cycloplegics\" title=\"Mydriatics and cycloplegics\" count=\"2\" rel=\"backlink\">Mydriatics and cycloplegics</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"6\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_343\" namespace=\"/interactions/list-of-drug-interactions/antimuscarinics/atropine\" title=\"Atropine\" count=\"1\" rel=\"link\">Atropine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34553\" namespace=\"/drug-classes/antimuscarinics-eye\" title=\"ANTIMUSCARINICS (EYE)\" count=\"1\" rel=\"link\">ANTIMUSCARINICS (EYE)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34659\" namespace=\"/drug-classes/antimuscarinics-systemic\" title=\"ANTIMUSCARINICS (SYSTEMIC)\" count=\"1\" rel=\"link\">ANTIMUSCARINICS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74804\" namespace=\"/drugs/atropine-sulfate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75069\" namespace=\"/drugs/atropine-sulfate/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75143\" namespace=\"/drugs/atropine-sulfate/eye-drops\" title=\"Eye drops\" count=\"1\" rel=\"link\">Eye drops</xref>\n</links>\n</topic>",
    "id": "PHP356",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/atropine-sulfate",
    "basename": "atropine-sulfate",
    "title": "ATROPINE SULFATE",
    "interactants": [
        {
            "id": "bnf_int_343",
            "label": "Atropine"
        }
    ],
    "vtmid": "73949004",
    "drugClassification": [
        "Antimuscarinics"
    ],
    "inheritsFromClass": [
        "ANTIMUSCARINICS (EYE)",
        "ANTIMUSCARINICS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Cycloplegia",
                        "html": "Cycloplegia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye using eye drop"
                    ],
                    "textContent": "To the eye using eye drop",
                    "html": "To the eye using eye drop"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Anterior uveitis",
                        "html": "Anterior uveitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye using eye drop"
                    ],
                    "textContent": "To the eye using eye drop",
                    "html": "To the eye using eye drop"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Bradycardia due to acute massive overdosage of beta-blockers",
                        "html": "Bradycardia due to acute massive overdosage of beta-blockers"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "child": [
                    {
                        "textContent": "40 micrograms/kg (max. per dose 3 mg).",
                        "html": "<p>40&#8239;micrograms/kg (max. per dose 3&#8239;mg).</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "3 mg.",
                        "html": "<p>3&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of poisoning by organophosphorus insecticide or nerve agent (in combination with pralidoxime chloride)",
                        "html": "Treatment of poisoning by organophosphorus insecticide or nerve agent (in combination with pralidoxime chloride)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "child": [
                    {
                        "textContent": "20 micrograms/kg every 5&#8211;10 minutes (max. per dose 2 mg) until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.",
                        "html": "<p>20&#8239;micrograms/kg every 5&#8211;10&#8239;minutes (max. per dose 2&#8239;mg) until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "2 mg every 5&#8211;10 minutes until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.",
                        "html": "<p>2&#8239;mg every 5&#8211;10&#8239;minutes until the skin becomes flushed and dry, the pupils dilate, and bradycardia is abolished, frequency of administration dependent on the severity of poisoning.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasm",
                        "html": "Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasm"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "0.6&#8211;1.2 mg daily, dose to be taken at night.",
                        "html": "<p>0.6&#8211;1.2&#8239;mg daily, dose to be taken at night.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Premedication",
                        "html": "Premedication"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection or intramuscular injection"
                    ],
                    "textContent": "By subcutaneous injection or by intramuscular injection",
                    "html": "By subcutaneous injection or by intramuscular injection"
                },
                "child": [
                    {
                        "textContent": "300&#8211;600 micrograms, to be administered immediately before induction of anaesthesia.",
                        "html": "<p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>",
                        "ageGroup": "12&#8211;17 years"
                    },
                    {
                        "textContent": "300&#8211;600 micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.",
                        "html": "<p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "300&#8211;600 micrograms, to be administered immediately before induction of anaesthesia.",
                        "html": "<p>300&#8211;600&#8239;micrograms, to be administered immediately before induction of anaesthesia.</p>"
                    },
                    {
                        "textContent": "300&#8211;600 micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.",
                        "html": "<p>300&#8211;600&#8239;micrograms, to be administered 30&#8211;60 minutes before induction of anaesthesia.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Intra-operative bradycardia",
                        "html": "Intra-operative bradycardia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "child": [
                    {
                        "textContent": "300&#8211;600 micrograms, larger doses may be used in emergencies.",
                        "html": "<p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "300&#8211;600 micrograms, larger doses may be used in emergencies.",
                        "html": "<p>300&#8211;600&#8239;micrograms, larger doses may be used in emergencies.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block",
                        "html": "Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "child": [
                    {
                        "textContent": "0.6&#8211;1.2 mg.",
                        "html": "<p>0.6&#8211;1.2&#8239;mg.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "0.6&#8211;1.2 mg.",
                        "html": "<p>0.6&#8211;1.2&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Excessive bradycardia associated with beta-blocker use",
                        "html": "Excessive bradycardia associated with beta-blocker use"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "0.6&#8211;2.4 mg every hour in divided doses (max. per dose 600 micrograms).",
                        "html": "<p>0.6&#8211;2.4&#8239;mg every hour in divided doses (max. per dose 600&#8239;micrograms).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Bradycardia following myocardial infarction (particularly if complicated by hypotension)",
                        "html": "Bradycardia following myocardial infarction (particularly if complicated by hypotension)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "500 micrograms every 3&#8211;5 minutes; maximum 3 mg.",
                        "html": "<p>500&#8239;micrograms every 3&#8211;5&#8239;minutes; maximum 3&#8239;mg.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by eye in children",
                    "html": "When used by <ph outputclass=\"route\">eye</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Not licensed for use in children for uveitis.",
                "html": "<p>Not licensed for use in children for uveitis.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With systemic use in children",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Not licensed for use by oral route.\n\nNot licensed for use in children under 12 years for intra-operative bradycardia or by intravenous route for premedication.\n\nNot licensed for the control of muscarinic side-effects of edrophonium in reversal of competitive neuromuscular block.",
                "html": "<p>Not licensed for use by oral route.</p><p>Not licensed for use in children under 12 years for intra-operative bradycardia or by intravenous route for premedication.</p><p>Not licensed for the control of muscarinic side-effects of edrophonium in reversal of competitive neuromuscular block.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.",
                "html": "<p>Antimuscarininc drugs used for premedication to general anaesthesia should only be administered by, or under the direct supervision of, personnel experienced in their use.</p>"
            }
        ]
    },
    "sideEffects": {
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "When used by eye in children",
                    "html": "When used by <ph outputclass=\"route\">eye</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Toxic systemic reactions can occur in neonates and children.",
                "html": "<p>Toxic systemic reactions can occur in neonates and children.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "When used by eye",
                    "html": "When used by <ph outputclass=\"route\">eye</ph>",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Systemic side-effects can occur, particularly in children and the elderly.",
                "html": "<p>Systemic side-effects can occur, particularly in children and the elderly.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Not known to be harmful; manufacturer advises caution.",
                "html": "<p>Not known to be harmful; manufacturer advises caution.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "May suppress lactation; small amount present in milk&#8212;manufacturer advises caution.",
                "html": "<p>May suppress lactation; small amount present in milk&#8212;manufacturer advises caution.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "title": "Control of muscarinic side-effects of neostigmine in reversal of competitive neuromuscular block",
                "textContent": "Since atropine has a shorter duration of action than neostigmine, late unopposed bradycardia may result; close monitoring of the patient is necessary.",
                "html": "<p>Since atropine has a shorter duration of action than neostigmine, late unopposed bradycardia may result; close monitoring of the patient is necessary.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For administration by mouth, injection solution may be given orally.",
                "html": "<p>For administration <i>by mouth</i>, injection solution may be given orally.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "When used by eye",
                    "html": "When used by <ph outputclass=\"route\">eye</ph>",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Although multi-dose atropine sulphate eye drops commonly contain preservatives, preservative-free unit dose vials may be available.",
                "html": "<p>Although multi-dose atropine sulphate eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Atropine tablets less suitable for prescribing. Any clinical benefit as a gastro-intestinal antispasmodic is outweighed by atropinic side-effects.",
                "html": "<p>Atropine tablets less suitable for prescribing. Any clinical benefit as a gastro-intestinal antispasmodic is outweighed by atropinic side-effects.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With intramuscular use or intravenous use or subcutaneous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use",
                    "routes": [
                        "intramuscular",
                        "intravenous",
                        "subcutaneous"
                    ]
                },
                "textContent": "Prescription only medicine restriction does not apply where administration is for saving life in emergency.",
                "html": "<p>Prescription only medicine restriction does not apply where administration is for saving life in emergency.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "eye drops",
                "solution for injection",
                "oral suspension",
                "solution for infusion",
                "oral solution",
                "eye ointment"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74804",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75069",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75143",
                "label": "Eye drops",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78105",
                "label": "Cardiopulmonary resuscitation",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78171",
                "label": "Sympathomimetics",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78203",
                "label": "Cardiac glycosides",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78219",
                "label": "Antispasmodics",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78291",
                "label": "Arrhythmias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78426",
                "label": "Neuromuscular blockade",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78500",
                "label": "Pre-medication and peri-operative drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78505",
                "label": "Neuromuscular disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78525",
                "label": "Mydriatics and cycloplegics",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_343",
                "label": "Atropine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34553",
                "label": "ANTIMUSCARINICS (EYE)",
                "type": "drugClass"
            },
            {
                "id": "PHP34659",
                "label": "ANTIMUSCARINICS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74804",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75069",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75143",
                "label": "Eye drops",
                "type": "medicinalForm"
            }
        ]
    }
}